VIM and breast carcinoma: Specifically, in this study, we perform immunohistochemical and bioinformatic analyses to investigate the possible prognostic role of vimentin, SDF-1, BMP-2, BMP-4, PTX3, OPN, RANKL, and Runx2 on a large cohort of breast cancer patients.